Sign inJoin waitlistJoin the waitlist

Chukwuemeka Ikpeazu

Associate Professor of Clinical Medicine, Medical Oncology · University of Miami/Jackson Health System

Credentials: · · · · · ·

History

University of Miami/Jackson Health System
Present

East Tennessee State University
1995–1997
Mayo Clinic College of Medicine and Science
1992–1995
Meharry Medical College
1988–1992

Research

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer
Molecular Cancer Therapeutics · 2021 · 184 citations
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Journal of Clinical Oncology · 2019 · 82 citations
Therapeutic strategies in RET gene rearranged non-small cell lung cancer
Review · Journal of Hematology & Oncology · 2021 · Last of 4 authors · Corresponding · 57 citations

AS
Ammar Sukari
3 papers
Barbara Burtness
3 papers
WK
Wolfgang Korn
3 papers
AS
Alexander Spira
2 papers
AW
Antoinette Wozniak
2 papers
Chul Kim
2 papers
EK
Edward Kim
2 papers
Estelamari Rodriguez
2 papers
HS
Hira Shaikh
2 papers · 1 as a fellow
HM
Hirva Mamdani
2 papers
Hossein Borghaei
2 papers
Luis Raez
2 papers

Clinical trials

Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
Principal investigator · Withdrawn · Phase 2
University of Miami
2022
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Site PI · Recruiting · Phase 2
PrECOG, LLC.
2026–2030
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2023–2030